Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 402, 471-472 (2 December 1999) | doi:10.1038/44973
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Associate Professor or Full Professor
- South Dakota State University
- Brookings, SD
Chemical Reaction Engineering & Reactor Design
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Alzheimer's disease: A firm base for drug development
Bart De Strooper & Gerhard König
Alzheimer's disease is a progressive dementia in which massive deposits of aggregated protein-breakdown products — amyloid plaques and neurofibrillary tangles — accumulate in the brain. The amyloid plaques are thought to be responsible for the devastating mental decline in patients with Alzheimer's disease, and the main component of these plaques is a small peptide called amyloid 
(A).
To read this story in full you will need to login or make a payment (see right).
